Hualan Biological Engineering Inc. (SHE:002007)
China flag China · Delayed Price · Currency is CNY
11.73
+0.05 (0.43%)
Nov 17, 2026, 3:04 PM CST

SHE:002007 Financials Overview

Millions CNY. Fiscal year is Jan - Dec.

Revenue & Profits

Fiscal Year
TTMFY 2025FY 2024FY 2023FY 2022FY 2021
Period EndingSep '26 Dec '25 Dec '24 Dec '23 Jan '23 Jan '22
Revenue
3,7984,5954,3795,3424,5174,436
Revenue Growth
-10.99%4.93%-18.02%18.26%1.82%-11.69%
Gross Profit
1,7902,5822,6113,6152,8182,898
Operating Income
639.531,1301,1791,8101,2231,586
Net Income
586.58940.41,0881,4821,0761,299
Earnings Per Share
0.320.520.590.810.590.71
EPS Growth
-38.06%-13.41%-26.75%37.92%-17.00%-19.95%

Revenue by Segment

Fiscal Year
FY 2025FY 2024FY 2023FY 2022FY 2021
Period EndingDec '25 Dec '24 Dec '23 Jan '23 Jan '22
Blood Product
3,3873,2462,9262,6792,598
Vaccine Product
1,1951,1172,4051,8181,825
Others
12.8816.3410.8920.2113.86
Total
4,5954,3795,3424,5174,436

Cash & Debt

Fiscal Year
CurrentFY 2025FY 2024FY 2023FY 2022FY 2021
Period EndingSep '26 Dec '25 Dec '24 Dec '23 Jan '23 Jan '22
Cash & Investments
5,3754,4035,3984,3223,7083,352
Total Debt
608.36455.78908.881,0101,1101,001
Net Cash (Debt)
4,7673,9474,4893,3122,5982,351
Net Cash Growth
-3.88%-12.07%35.54%27.50%10.51%-35.14%
Net Cash Per Share
2.612.162.461.821.421.28

Cash Flow & CapEx

Fiscal Year
TTMFY 2025FY 2024FY 2023FY 2022FY 2021
Period EndingSep '26 Dec '25 Dec '24 Dec '23 Jan '23 Jan '22
Operating Cash Flow
799.98877.961,0591,346957.311,432
Capital Expenditures
-181.35-197.31-255.43-753.41-393.95-811.35
Free Cash Flow
618.63680.65803.92592.43563.36621.15
Free Cash Flow Growth
-43.96%-15.33%35.70%5.16%-9.30%-11.75%

Margins

Fiscal Year
TTMFY 2025FY 2024FY 2023FY 2022FY 2021
Period EndingSep '26 Dec '25 Dec '24 Dec '23 Jan '23 Jan '22
Gross Margin
47.14%56.19%59.62%67.67%62.38%65.33%
Operating Margin
16.84%24.58%26.92%33.89%27.08%35.76%
Pretax Margin
18.96%25.54%30.57%38.89%31.62%38.06%
Profit Margin
15.44%20.47%24.84%27.73%23.83%29.28%
FCF Margin
16.29%14.81%18.36%11.09%12.47%14.00%

Dividends

Fiscal Year
CurrentFY 2025FY 2024FY 2023FY 2022FY 2021
Period EndingNov '26 Dec '25 Dec '24 Dec '23 Jan '23 Jan '22
Dividend Per Share
0.4001.0000.2000.3000.3000.200
Dividend Per Share Growth
0%400.00%-33.33%0%50.00%-33.33%
Dividend Yield
3.41%6.61%1.19%1.36%1.33%0.69%

Valuation

Fiscal Year
CurrentFY 2025FY 2024FY 2023FY 2022FY 2021
Period EndingNov '26 Dec '25 Dec '24 Dec '23 Jan '23 Jan '22
PE Ratio
36.4729.4028.3327.3238.3640.93
Forward PE
19.6915.9319.3723.0528.4727.36
P/FCF Ratio
35.0640.6238.3368.3173.2885.59
PS Ratio
5.716.027.047.589.1411.98